Pharmaceutical giant Eli Lilly is slashing the list prices for some of its most popular insulin products by 70 percent and capping insulin copays at $35 for uninsured patients and those with private ...

Pharmaceutical giant Eli Lilly is slashing the list prices for some of its most popular insulin products by 70 percent and capping insulin copays at US$35 for uninsured patients and those with private ...

SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- ...

Uninsured Americans are still having challenges accessing affordable insulin, despite Eli Lilly’s decision to cap its generic version, Lispro, at $25 per vial, according to a report Sen. Elizabeth ...

Pharmaceutical company Eli Lilly will sell a cheaper generic version of its rapid-acting insulin Humalog, according to a statement Monday from Chairman and CEO Dave Ricks. Pharmaceutical company Eli ...

A half-price version of Eli Lilly’s popular Humalog insulin is now available, following the company’s promise in March to offer diabetics a more affordable option amid fierce criticism of soaring ...